Predictors of diabetic nephropathy

Central European Journal of Medicine

Volumn 8, Issue 3, 2013, Pages 287-296

  Gaballa, Mahmoud R ^a   Farag, Youssef M K ^b  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Chronic kidney disease; Diabetes; Diabetic nephropathy; Markers; Microalbuminuria; Predictors; Risk factors

Indexed keywords

BIOLOGICAL MARKER; CREATININE; FATTY ACID BINDING PROTEIN; LIVER TYPE FATTY ACID BINDING PROTEIN; NEPHRIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; SERUM ALBUMIN; UNCLASSIFIED DRUG; URIC ACID;

AGE; ANEMIA; DIABETIC NEPHROPATHY; DISEASE COURSE; ECCENTRIC VENTRICULAR HYPERTROPHY; GLOMERULUS FILTRATION RATE; HEART VENTRICLE HYPERTROPHY; HIGH RISK POPULATION; HUMAN; HYPERTENSION; KIDNEY HYPERTROPHY; MICROALBUMINURIA; MOLECULAR PATHOLOGY; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SLEEP DISORDERED BREATHING; SMOKING; URIC ACID BLOOD LEVEL; URINE ALBUMIN CREATININE RATIO; URINE LEVEL; URINE NEPHRIN CREATININE RATIO; UROGENITAL SYSTEM PARAMETERS;

EID: 84877875202     PISSN: 18951058     EISSN: 16443640     Source Type: Journal    
DOI: 10.2478/s11536-012-0055-3     Document Type: Review

References (74)

1. Foley, R.N. and A.J. Collins, The growing economic burden of diabetic kidney disease. Curr Diab Rep, 2009. 9(6): p. 460-465
2. Farag, Y.M. and M.R. Gaballa, Diabesity: an overview of a rising epidemic. Nephrol Dial Transplant, 2011. 26(1): p. 28-35
3. Shaw, J.E., R.A. Sicree, and P.Z. Zimmet, Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract, 2010. 87(1): p. 4-14
4. Plantinga, L.C., et al., Prevalence of chronic kidney disease in US adults with undiagnosed diabetes or prediabetes. Clin J Am Soc Nephrol, 2010. 5(4): p. 673-682
5. Abougalambou, S.S.I., et al., Prevalence of Vascular Complications among Type 2 Diabetes Mellitus Outpatients at Teaching Hospital in Malaysia. J Diabet Metabol, 2011. 2:115
6. Singh, D.K., P. Winocour, and K. Farrington, Oxidative stress in early diabetic nephropathy: fueling the fire. Nat Rev Endocrinol, 2010
7. Fioretto, P., et al., An overview of renal pathology in insulin-dependent diabetes mellitus in relationship to altered glomerular hemodynamics. Am J Kidney Dis, 1992. 20(6): p. 549-558
8. Adler, S., Diabetic nephropathy: Linking histology, cell biology, and genetics. Kidney Int, 2004. 66(5): p. 2095-2106
9. Alexander, M.P., et al., Kidney pathological changes in metabolic syndrome: a cross-sectional study. Am J Kidney Dis, 2009. 53(5): p. 751-759.
10. Farag, Y.M., Metabolic syndrome and the nonneoplastic kidney. Adv Anat Pathol, 2011. 18(2): p. 173; author reply 174
11. Nosadini, R., et al., Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate. Diabetes, 2000. 49(3): p. 476-484
12. Keck, M., et al., Hormonal status affects the progression of STZ-induced diabetes and diabetic renal damage in the VCD mouse model of menopause. Am J Physiol Renal Physiol, 2007. 293(1): p. F193-199
13. Mankhey, R.W., F. Bhatti, and C. Maric, 17beta-Estradiol replacement improves renal function and pathology associated with diabetic nephropathy. Am J Physiol Renal Physiol, 2005. 288(2): p. F399-405
14. Reckelhoff, J.F., et al., Testosterone supplementation in aging men and women: possible impact on cardiovascular-renal disease. Am J Physiol Renal Physiol, 2005. 289(5): p. F941-948
15. Mollsten, A., et al., Cumulative risk, age at onset, and sex-specific differences for developing endstage renal disease in young patients with type 1 diabetes: a nationwide population-based cohort study. Diabetes, 2010. 59(7): p. 1803-1808
16. Morimoto, A., et al., Is pubertal onset a risk factor for blindness and renal replacement therapy in childhood-onset type 1 diabetes in Japan? Diabetes Care, 2007. 30(9): p. 2338-2340
17. Harvey, J.N., The influence of sex and puberty on the progression of diabetic nephropathy and retinopathy. Diabetologia, 2011. 54(8): p. 1943-1945
18. Finne, P., et al., Incidence of end-stage renal disease in patients with type 1 diabetes. JAMA, 2005. 294(14): p. 1782-1787
19. Raile, K., et al., Diabetic nephropathy in 27,805 children, adolescents, and adults with type 1 diabetes: effect of diabetes duration, A1C, hypertension, dyslipidemia, diabetes onset, and sex. Diabetes Care, 2007. 30(10): p. 2523-2528
20. Svensson, M., et al., Age at onset of childhoodonset type 1 diabetes and the development of end-stage renal disease: a nationwide population-based study. Diabetes Care, 2006. 29(3): p. 538-542
21. Dahlquist, G. and S. Rudberg, The prevalence of microalbuminuria in diabetic children and adolescents and its relation to puberty. Acta Paediatr Scand, 1987. 76(5): p. 795-800
22. Olsen, B.S., et al., The significance of the prepubertal diabetes duration for the development of retinopathy and nephropathy in patients with type 1 diabetes. J Diabetes Complications, 2004. 18(3): p. 160-164
23. Yacoub, R., et al., Association between smoking and chronic kidney disease: a case control study. BMC Public Health, 2010. 10: p. 731.
24. Sawicki, P.T., et al., Smoking is associated with progression of diabetic nephropathy. Diabetes Care, 1994. 17(2): p. 126-131
25. Rossing, P., P. Hougaard, and H.H. Parving, Risk factors for development of incipient and overt diabetic nephropathy in type 1 diabetic patients: a 10-year prospective observational study. Diabetes Care, 2002. 25(5): p. 859-864
26. Stegmayr, B.G., A study of patients with diabetes mellitus (type 1) and end-stage renal failure: tobacco usage may increase risk of nephropathy and death. J Intern Med, 1990. 228(2): p. 121-124
27. Chuahirun, T. and D.E. Wesson, Cigarette smoking predicts faster progression of type 2 established diabetic nephropathy despite ACE inhibition. Am J Kidney Dis, 2002. 39(2): p. 376-382
28. Orth, S.R., Smoking - a renal risk factor. Nephron, 2000. 86(1): p. 12-26
29. Jaimes, E.A., R.X. Tian, and L. Raij, Nicotine: the link between cigarette smoking and the progression of renal injury? Am J Physiol Heart Circ Physiol, 2007. 292(1): p. H76-82
30. Marangon, K., et al., Diet, antioxidant status, and smoking habits in French men. Am J Clin Nutr, 1998. 67(2): p. 231-239
31. Cross, C.E., A. van der Vliet, and J.P. Eiserich, Cigarette smokers and oxidant stress: a continuing mystery. Am J Clin Nutr, 1998. 67(2): p. 184-185
32. Hu, Y., et al., Relations of glycemic index and glycemic load with plasma oxidative stress markers. Am J Clin Nutr, 2006. 84(1): p. 70-76; quiz 266-267
33. Chabrashvili, T., et al., Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney. Hypertension, 2002. 39(2): p. 269-274
34. Gorin, Y., et al., Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney. J Biol Chem, 2005. 280(47): p. 39616-39626
35. Hua, P., et al., Nicotine worsens the severity of nephropathy in diabetic mice: implications for the progression of kidney disease in smokers. Am J Physiol Renal Physiol, 2010. 299(4): p. F732-739
36. Sharma, K., P. McCue, and S.R. Dunn, Diabetic kidney disease in the db/db mouse. Am J Physiol Renal Physiol, 2003. 284(6): p. F1138-1144
37. Waugh, N.R., et al., Mortality in a cohort of diabetic patients. Causes and relative risks. Diabetologia, 1989. 32(2): p. 103-104
38. Sturrock, N.D., et al., Non-dipping circadian blood pressure and renal impairment are associated with increased mortality in diabetes mellitus. Diabet Med, 2000. 17(5): p. 360-364
39. Epstein, M. and J.R. Sowers, Diabetes mellitus and hypertension. Hypertension, 1992. 19(5): p. 403-418
40. Farmer, C.K., et al., Progression of diabetic nephropathy - is diurnal blood pressure rhythm as important as absolute blood pressure level? Nephrol Dial Transplant, 1998. 13(3): p. 635-639
41. Verdecchia, P., et al., Blunted nocturnal fall in blood pressure in hypertensive women with future cardiovascular morbid events. Circulation, 1993. 88(3): p. 986-992
42. Borch-Johnsen, K., P.K. Andersen, and T. Deckert, The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus. Diabetologia, 1985. 28(8): p. 590-596
43. Hansen, H.P., et al., Circadian rhythm of arterial blood pressure and albuminuria in diabetic nephropathy. Kidney Int, 1996. 50(2): p. 579-585
44. Lurbe, E., et al., Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med, 2002. 347(11): p. 797-805
45. Lurbe, A., et al., Altered blood pressure during sleep in normotensive subjects with type I diabetes. Hypertension, 1993. 21(2): p. 227-235
46. Moore, W.V., et al., Ambulatory blood pressure in type I diabetes mellitus. Comparison to presence of incipient nephropathy in adolescents and young adults. Diabetes, 1992. 41(9): p. 1035-1041
47. Lafferty, A.R., G.A. Werther, and C.F. Clarke, Ambulatory blood pressure, microalbuminuria, and autonomic neuropathy in adolescents with type 1 diabetes. Diabetes Care, 2000. 23(4): p. 533-538
48. Felicio, J.S., et al., Nocturnal blood pressure fall as predictor of diabetic nephropathy in hypertensive patients with type 2 diabetes. Cardiovasc Diabetol, 2010. 9: p. 36
49. Magri, C.J., et al., Factors associated with diabetic nephropathy in subjects with proliferative retinopathy. Int Urol Nephrol, 2011
50. Ip, M.S., et al., Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med, 2002. 165(5): p. 670-676
51. Ozol, D., et al., Influence of snoring on microalbuminuria in diabetic patients. Sleep Breath, 2010
52. Netzer, N.C., et al., Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med, 1999. 131(7): p. 485-491
53. Hovind, P., et al., Serum uric acid as a predictor for development of diabetic nephropathy in type 1 diabetes: an inception cohort study. Diabetes, 2009. 58(7): p. 1668-1671
54. Kosugi, T., et al., Effect of lowering uric acid on renal disease in the type 2 diabetic db/db mice. Am J Physiol Renal Physiol, 2009. 297(2): p. F481-488
55. Kanakamani, J., et al., Prevalence of microalbuminuria among patients with type 2 diabetes mellitus - a hospital-based study from north India. Diabetes Technol Ther, 2010. 12(2): p. 161-166
56. Hoefield, R.A., et al., The use of eGFR and ACR to predict decline in renal function in people with diabetes. Nephrol Dial Transplant, 2010
57. Rossing, P., et al., Monitoring kidney function in type 2 diabetic patients with incipient and overt diabetic nephropathy. Diabetes Care, 2006. 29(5): p. 1024-1030
58. Phillips, A.O. and R. Steadman, Diabetic nephropathy: the central role of renal proximal tubular cells in tubulointerstitial injury. Histol Histopathol, 2002. 17(1): p. 247-252
59. Kanauchi, M., H. Nishioka, and T. Hashimoto, Oxidative DNA damage and tubulointerstitial injury in diabetic nephropathy. Nephron, 2002. 91(2): p. 327-329
60. Nielsen, S.E., et al., Urinary liver-type fatty acidbinding protein predicts progression to nephropathy in type 1 diabetic patients. Diabetes Care, 2010. 33(6): p. 1320-1324
61. Kamijo-Ikemori, A., et al., Clinical Significance of Urinary Liver-Type Fatty Acid Binding Protein in Diabetic Nephropathy of Type 2 Diabetic Patients. Diabetes Care, 2011
62. Nielsen, S.E., et al., Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy. Kidney Int, 2011. 79(10): p. 1113-1118
63. Aaltonen, P., et al., Changes in the expression of nephrin gene and protein in experimental diabetic nephropathy. Lab Invest, 2001. 81(9): p. 1185-1190
64. Luimula, P., et al., Nephrin in experimental glomerular disease. Kidney Int, 2000. 58(4): p. 1461-1468
65. Qipo, A., H.W. Cohen, and B. Jim, 256 Urinary Nephrin as an Early Biomarker of Diabetic Nephropathy. American journal of kidney diseases: the official journal of the National Kidney Foundation, 2011. 57(4): p. B80
66. Rutter, M.K., et al., Increased left ventricular mass index and nocturnal systolic blood pressure in patients with Type 2 diabetes mellitus and microalbuminuria. Diabet Med, 2000. 17(4): p. 321-325
67. Suzuki, K., et al., Left ventricular mass index increases in proportion to the progression of diabetic nephropathy in Type 2 diabetic patients. Diabetes Res Clin Pract, 2001. 54(3): p. 173-180
68. Moon, S.J., et al., The effect of anemia and left ventricular geometric patterns on renal disease progression in type 2 diabetic nephropathy. J Nephrol, 2011. 24(1): p. 50-59
69. Rigalleau, V., et al., Large kidneys predict poor renal outcome in subjects with diabetes and chronic kidney disease. BMC Nephrol, 2010. 11: p. 3
70. Zerbini, G., et al., Persistent renal hypertrophy and faster decline of glomerular filtration rate precede the development of microalbuminuria in type 1 diabetes. Diabetes, 2006. 55(9): p. 2620-2625
71. Ablett, M.J., et al., How reliable are ultrasound measurements of renal length in adults? Br J Radiol, 1995. 68(814): p. 1087-1089
72. Elliott J, Mishler D, Agarwal R. Hyporesponsiveness to erythropoietin: causes and management. Adv Chronic Kidney Dis. 2009 Mar;16(2):94-100
73. Keithi-Reddy SR, Addabbo F, Patel TV, Mittal BV, Goligorsky MS, Singh AK. Association of anemia and erythropoiesis stimulating agents with inflammatory biomarkers in chronic kidney disease. Kidney Int. 2008
74. Inrig JK, Bryskin SK, Patel UD, Arcasoy M, Szczech LA. Association between high-dose erythropoiesis-stimulating agents, inflammatory biomarkers, and soluble erythropoietin receptors. BMC Nephrol. 2011 Dec 12;12:67